Table 1 Visual assessment of CT for test set participants
|  | Total | GT PRMfSAD > 15% | GT PRMfSAD ≤ 15% |
|---|---|---|---|
No. of subjects | 76 | 46 | 30 |
CLE | Â | Â | Â |
 Total | 68 (63.2) | 33 (71.7) | 15 (50) |
 Trace | 26 (34.2) | 16 (34.8) | 10 (33.4) |
 Mild | 16(21.1) | 12 (26) | 4 (13.3) |
 Moderate | 5 (6.6) | 5 (10.9) | 0 (0) |
 Confluent | 1 (1.3) | 0 (0) | 1 (3.3) |
 ADE | 0 (0) | 0 (0) | 0 (0) |
Panlobular emphysema | Â | Â | Â |
 No | 73 (96.1) | 44 (95.7) | 29 (96.7) |
 Yes | 3 (3.9) | 2 (4.3) | 1 (3.3) |
Paraseptal emphysema | Â | Â | Â |
 Total | 21 (27.7) | 16 (34.8) | 5 (16.7) |
 Mild | 11 (14.5) | 9 (19.6) | 2 (6.7) |
 Substantial | 10 (13.2) | 7 (15.2) | 3 (10) |
Bronchial wall thickening | Â | Â | Â |
 No | 72 (94.7) | 44 (95.7) | 28 (93.3) |
 Yes | 4 (5.3) | 2 (4.3) | 2 (6.7) |
Bronchial dilation | Â | Â | Â |
 Total | 24 (31.6) | 17 (37) | 7 (23.3) |
 Single Lung Segment | 19 (25) | 13 (28.3) | 6 (20) |
 Multiple Lung Segments | 5 (6.6) | 4 (8.7) | 1 (3.3) |
 Extensive Lung Segments | 0 (0) | 0 (0) | 0 (0) |
Inflammatory SAD | Â | Â | Â |
 Total | 29 (38.1) | 25 (54.3) | 4 (13.4) |
 Single Lung Segment | 19 (25) | 17 (36.9) | 2 (6.7) |
 Multiple Lung Segments | 9 (11.8) | 7 (15.2) | 2 (6.7) |
 Extensive Lung Segments | 1 (1.3) | 1 (2.2) | 0 (0) |